Numerous studies have demonstrated that EEF2K is involved in various tumour‐associated processes, including cell cycle, apoptosis, angiogenesis, epithelial–mesenchymal transition and sensitivity to chemotherapies in tumour progression.4, 5. Here, EEF2K is linked to neoplasm.